Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2015

Other information pertaining to share-based activity during the three and nine months ended September 30, 2015 and 2014 was as follows (in thousands):



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2014		2015		2014
Share-based compensation expense	$	3,727	$	2,424	$	11,319	$	7,388
Fair value of shares vested	—		123		13,220		10,481
Cash received from option exercises	276		504		2,356		2,150
Tax benefit from exercises of share based awards	246		198		3,779		2,288

Schedule Of Changes In Non-Vested Restricted Shares

A summary of the status of non-vested restricted shares at September 30, 2015 and changes during the nine months ended September 30, 2015 is as follows:



			Weighted
	Number		Average
	of Shares		Grant Price
Non-vested shares at December 31, 2014	668,109		$	33.51
Shares granted	313,498		56.19
Shares vested	(233,831	)	28.19
Shares forfeited	(6,983	)	39.88
Non-vested shares at September 30, 2015	740,793		$	44.73

Schedule Of Stock Option Activity

A summary of stock option activity for the nine months ended September 30, 2015 is summarized as follows:



					Weighted
			Weighted		Average
			Average		Remaining
	Number		Exercise		Contractual
	of Shares		Price		Term (in years)
Outstanding at December 31, 2014	158,721		$	22.89	1.7
Options exercised with total intrinsic value of $4.2 million	(102,762	)	22.92
Options terminated	(11,750	)	23.42
Outstanding, Vested and Exercisable at September 30, 2015 with an aggregate intrinsic value of $2.4 million	44,209		$	22.70	1.0

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

The following is a reconciliation of the numerator and denominators of basic and diluted earnings (loss) per share (in thousands, except per share amounts):



	Three Months Ended September 30,							Nine Months Ended September 30,
	Earnings			Shares	Per Share			Earnings		Shares	Per Share
	(Numerator)			(Denominator)	Amount			(Numerator)		(Denominator)	Amount
2015:
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	40,397		47,707	$	0.85		$	90,582	47,652	$	1.90
Preferred stock dividends	2,264			—				—		—
Effect of dilutive securities, options and non-vested shares	—			3,568				—		398
Net earnings from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	42,661		51,275	$	0.83		$	90,582	48,050	$	1.89

2014:
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (basic)	$	(10,697	)	46,320	$	(0.23	)	$	25,466	36,620	$	0.70
Effect of dilutive securities, options and non-vested shares	—			—				—		406
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (diluted)	$	(10,697	)	46,320	$	(0.23	)	$	25,466	37,026	$	0.69